deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT00970658

Efficacy and Safety of Salonsip Compared to Sabiá Plaster (SAL-SIP-03/09)

Clinical Multicenter Study, Randomized, Open, to Evaluate the Efficacy and Safety of Salonsip Compared to Sabiá Plaster Relief of the Signs and Symptoms in Patients With Contusions, Sprains, Injuries and Muscular Injuries With Less Than 24 Hours Early or Holders of Myalgia, Pain and Tendonitis in Regions Miofasciais Articulated.

Sponsor: Hisamitsu Farmaceutica do Brasil Ltda

Updated 5 times since 2017 Last updated: Sep 3, 2009 Started: Dec 31, 2009 Primary completion: Jan 31, 2010 Completion: Feb 28, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00970658, this PHASE3 trial focuses on Contusions and Myalgia and remains ongoing. Sponsored by Hisamitsu Farmaceutica do Brasil Ltda, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 23 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hisamitsu Farmaceutica do Brasil Ltda
Data source: Hisamitsu Farmaceutica do Brasil Ltda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.